My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 158

    1.

    Activated Akt1 accelerates MMTV-c-ErbB2 mammary tumourigenesis in mice without activation of ErbB3.

    Young CD, Nolte EC, Lewis A, Serkova NJ, Anderson SM.

    Breast Cancer Res. 2008;10(4):R70. Epub 2008 Aug 13.PMID: 18700973 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Heregulin beta1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.

    Hutcheson IR, Knowlden JM, Hiscox SE, Barrow D, Gee JM, Robertson JF, Ellis IO, Nicholson RI.

    Breast Cancer Res. 2007;9(4):R50.PMID: 17686159 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.

    Kim A, Liu B, Ordonez-Ercan D, Alvarez KM, Jones LD, McKimmey C, Edgerton SM, Yang X, Thor AD.

    Breast Cancer Res. 2005;7(5):R708-18. Epub 2005 Jul 6.PMID: 16168116 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.

    Xian W, Rosenberg MP, DiGiovanni J.

    Oncogene. 1997 Mar 27;14(12):1435-44.PMID: 9136987 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.

    Brockhoff G, Heiss P, Schlegel J, Hofstaedter F, Knuechel R.

    Cytometry. 2001 Aug 1;44(4):338-48.PMID: 11500850 [PubMed - indexed for MEDLINE]Related articles

    6.

    Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation.

    Contessa JN, Abell A, Mikkelsen RB, Valerie K, Schmidt-Ullrich RK.

    Breast Cancer Res Treat. 2006 Jan;95(1):17-27.PMID: 16267617 [PubMed - indexed for MEDLINE]Related articles

    7.

    Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.

    Kiguchi K, Bol D, Carbajal S, Beltrán L, Moats S, Chan K, Jorcano J, DiGiovanni J.

    Oncogene. 2000 Aug 31;19(37):4243-54.PMID: 10980598 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.

    Maegawa M, Takeuchi K, Funakoshi E, Kawasaki K, Nishio K, Shimizu N, Ito F.

    Mol Cancer Res. 2007 Apr;5(4):393-401.PMID: 17426253 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function.

    Ishizawar RC, Miyake T, Parsons SJ.

    Oncogene. 2007 May 24;26(24):3503-10. Epub 2006 Dec 18.PMID: 17173075 [PubMed - indexed for MEDLINE]Related articles

    10.

    Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.

    Maroulakou IG, Oemler W, Naber SP, Tsichlis PN.

    Cancer Res. 2007 Jan 1;67(1):167-77.PMID: 17210696 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.

    Yen L, Cao Z, Wu X, Ingalla ER, Baron C, Young LJ, Gregg JP, Cardiff RD, Borowsky AD, Sweeney C, Carraway KL 3rd.

    Cancer Res. 2006 Dec 1;66(23):11279-86.PMID: 17145873 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.

    Feroz K, Williams E, Riese DJ 2nd.

    Cell Signal. 2002 Sep;14(9):793-8.PMID: 12034361 [PubMed - indexed for MEDLINE]Related articles

    13.

    Enhanced drug resistance in cells coexpressing ErbB2 with EGF receptor or ErbB3.

    Chen X, Yeung TK, Wang Z.

    Biochem Biophys Res Commun. 2000 Nov 2;277(3):757-63.PMID: 11062025 [PubMed - indexed for MEDLINE]Related articles

    14.

    A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4.

    Lee H, Akita RW, Sliwkowski MX, Maihle NJ.

    Cancer Res. 2001 Jun 1;61(11):4467-73.PMID: 11389077 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    gamma-Tocotrienol inhibits ErbB3-dependent PI3K/Akt mitogenic signalling in neoplastic mammary epithelial cells.

    Samant GV, Sylvester PW.

    Cell Prolif. 2006 Dec;39(6):563-74.PMID: 17109639 [PubMed - indexed for MEDLINE]Related articles

    16.

    ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas.

    Schroeder JA, Adriance MC, McConnell EJ, Thompson MC, Pockaj B, Gendler SJ.

    J Biol Chem. 2002 Jun 21;277(25):22692-8. Epub 2002 Apr 11.PMID: 11950845 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice.

    Landis MD, Seachrist DD, Montañez-Wiscovich ME, Danielpour D, Keri RA.

    Oncogene. 2005 Aug 4;24(33):5173-90.PMID: 15897883 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells.

    Liu B, Ordonez-Ercan D, Fan Z, Edgerton SM, Yang X, Thor AD.

    Int J Cancer. 2007 May 1;120(9):1874-82.PMID: 17266042 [PubMed - indexed for MEDLINE]Related articles

    19.

    Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.

    Alimandi M, Wang LM, Bottaro D, Lee CC, Kuo A, Frankel M, Fedi P, Tang C, Lippman M, Pierce JH.

    EMBO J. 1997 Sep 15;16(18):5608-17.PMID: 9312020 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant.

    Frogne T, Benjaminsen RV, Sonne-Hansen K, Sorensen BS, Nexo E, Laenkholm AV, Rasmussen LM, Riese DJ 2nd, de Cremoux P, Stenvang J, Lykkesfeldt AE.

    Breast Cancer Res Treat. 2009 Mar;114(2):263-75. Epub 2008 Apr 14.PMID: 18409071 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity